MetaCap

Ocugen Statistics

NASDAQ: OCGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.7679+0.0351 (+4.79%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ocugen by the numbers

Ocugen has a market capitalization of $260.6 million based on 339.31M shares outstanding. With trailing EPS of $-0.20, Ocugen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.2% below its 50-day average and 44.1% below its 200-day average.

Average daily trading volume is 7.34M shares, or about $5.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

OCGN valuation vs. peer median

OCGN compared with the median of 8 peer companies
MetricOCGNPeer medianDifference
Market cap$260.55M$255.00M+2%
Avg. volume7.34M885.38K+729%

Peer median across 8 companies: EIKN, SABS, EDIT, AGMB, KYTX, AGEN, LXEO, PLX.

Valuation

Market cap
$260.55M
Price / sales (latest FY)
59.04
EPS (TTM)
$-0.20

Price and trading

Previous close
0.7328
Open
0.71
Day range
0.71 – 0.8198
52-week range
0.691 – 2.73
52-week change
-33.80%
Beta
—
Volume
6.19M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
260.55M
Forward Pe
-4.27
Eps
-0.20
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.73
Week52 Low
0.69
Avg Volume
7.34M
Shares Outstanding
339.31M
Ma50
0.90
Ma200
1.37
Earnings Date
Nov 4, 2026
Pct From52w High
-71.82%
Pct From52w Low
11.13%

Related